Document is current
Any future updates will be listed below
-
Authors
Dei Cas, Alessandra https://orcid.org/0000-0002-8666-4849
Aldigeri, Raffaella
Bellei, Giulia
Raffaeli, Davide
Di Bartolo, Paolo
Sforza, Alessandra
Marchesini, Giulio
Ciardullo, Anna Vittoria
Manicardi, Valeria
Bianco, Maurizio
Monesi, Marcello
Vacirca, Anna
Cimicchi, Maria Cristina
Sordillo, Paola Anna
Altini, Mattia
Fantuzzi, Federica
Bonadonna, Riccardo C
,
Magotti, Maria Grazia
Haddoub, Silvia
Turola, Elena
Di Seclì, Clelia
Ugolotti, Diletta
Marchignoli, Francesca
Petroni, Maria Letizia
Laffi, Gilberto
D’Urso, Rossella
Malchiodi, Elena
Manicardi, Elisa
Bonilauri, Lisa
Manini, Rita
Farabegoli, Costanza
Scolozzi, Patrizia
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04060732 at ClinicalTrials.govDocuments that mention this clinical trial
Effectiveness of the flash glucose monitoring system in preventing severe hypoglycemic episodes and in improving glucose metrics and quality of life in subjects with type 1 diabetes at high risk of acute diabetes complications
https://doi.org/10.1007/s00592-024-02298-x
-
Funding
Funding for this research was provided by:
Università degli Studi di Parma
- License Information
-
More Information
Article History
Received: 6 February 2024
Accepted: 21 April 2024
First Online: 4 June 2024
Declarations
:
: ADC has received lecture fees from MSD, AstraZeneca, Eli Lilly, Sanofi, DOC generici, Servier. PDB has been a board member/advisory panel for Abbott Italia, Astra Zeneca Italia, Allergan/Abvie, Bayer Italia, Boehringer Italia, Eli Lilly Italia, Glaxo Italia, Menarini Diagnostic, Novonordisk Italia, Sanofi Italia and speaker bureau for Abbott Italia, Astra Zeneca Italia, Allergan/Abbvie, Ascensia Italia, Bayer Italia, Boehringer Italia, Eli Lilly Italia, Guidotti, Insulet, Menarini Diagnostic, Novonordisk Italia, Sanofi Italia, Theras Italia. RCB has received lecture fees from AstraZeneca, Eli Lilly, Sanofi, MSD, Janssen and has been a board member/advisory panel for Eli Lilly, Sanofi, MSD, Amgen. RA, GB, DR, AS, GM, AVC, VM, MB, MM, AV, MCC, APS, MA, FF have no potential conflicts of interest. No other potential conflicts of interest relevant to this article were reported.
: This study was performed in compliance with the guidelines for the 1964 Declaration of Helsinki. This study was approved by the Ethics Committee “Comitato Etico per Parma” (approval No. 17719, 16/may/2017) and the ethics review committee of each participating center.
: All participants signed informed consent forms prior to inclusion in the study.
